Foresee Pharmaceuticals Statistics

Total Valuation

TPEX:6576 has a market cap or net worth of TWD 12.24 billion. The enterprise value is 11.14 billion.

Market Cap	12.24B
Enterprise Value	11.14B

Important Dates

The next estimated earnings date is Monday, May 12, 2025.

Earnings Date	May 12, 2025
Ex-Dividend Date	n/a

Share Statistics

TPEX:6576 has 154.79 million shares outstanding. The number of shares has increased by 7.90% in one year.

Current Share Class	n/a
Shares Outstanding	154.79M
Shares Change (YoY)	+7.90%
Shares Change (QoQ)	+3.01%
Owned by Insiders (%)	2.83%
Owned by Institutions (%)	2.63%
Float	126.69M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	25.94
PB Ratio	7.66
P/TBV Ratio	8.27
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-10.30
EV / Sales	26.60
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-8.42

Financial Position

The company has a current ratio of 4.62, with a Debt / Equity ratio of 0.16.

Current Ratio	4.62
Quick Ratio	3.63
Debt / Equity	0.16
Debt / EBITDA	n/a
Debt / FCF	-0.20
Interest Coverage	-160.97

Financial Efficiency

Return on equity (ROE) is -76.04% and return on invested capital (ROIC) is -40.51%.

Return on Equity (ROE)	-76.04%
Return on Assets (ROA)	-33.57%
Return on Invested Capital (ROIC)	-40.51%
Return on Capital Employed (ROCE)	-61.15%
Revenue Per Employee	n/a
Profits Per Employee	n/a
Employee Count	n/a
Asset Turnover	0.21
Inventory Turnover	1.15

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -19.27% in the last 52 weeks. The beta is 1.08, so TPEX:6576's price volatility has been similar to the market average.

Beta (5Y)	1.08
52-Week Price Change	-19.27%
50-Day Moving Average	82.17
200-Day Moving Average	81.09
Relative Strength Index (RSI)	29.66
Average Volume (20 Days)	215,766

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, TPEX:6576 had revenue of TWD 418.69 million and -1.08 billion in losses. Loss per share was -7.87.

Revenue	418.69M
Gross Profit	239.80M
Operating Income	-1.08B
Pretax Income	-1.03B
Net Income	-1.08B
EBITDA	-1.02B
EBIT	-1.08B
Loss Per Share	-7.87

Full Income Statement

Balance Sheet

The company has 1.37 billion in cash and 260.33 million in debt, giving a net cash position of 1.11 billion or 7.15 per share.

Cash & Cash Equivalents	1.37B
Total Debt	260.33M
Net Cash	1.11B
Net Cash Per Share	7.15
Equity (Book Value)	1.60B
Book Value Per Share	10.33
Working Capital	1.42B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -1.17 billion and capital expenditures -149.59 million, giving a free cash flow of -1.32 billion.

Operating Cash Flow	-1.17B
Capital Expenditures	-149.59M
Free Cash Flow	-1.32B
FCF Per Share	-8.55

Full Cash Flow Statement

Margins

Gross margin is 57.27%, with operating and profit margins of -257.90% and -258.20%.

Gross Margin	57.27%
Operating Margin	-257.90%
Pretax Margin	-246.77%
Profit Margin	-258.20%
EBITDA Margin	-242.56%
EBIT Margin	-257.90%
FCF Margin	n/a

Dividends & Yields

TPEX:6576 does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-7.90%
Shareholder Yield	-7.90%
Earnings Yield	-8.83%
FCF Yield	-10.81%

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

TPEX:6576 has an Altman Z-Score of 8.42.

Altman Z-Score	8.42
Piotroski F-Score	n/a